Skip to content

Effect of exclusion of bacteremia on antibiotic treatment

Observational study in critical care to assess if use of a diagnostic test to exclude bacteremia would affect clinical decision making

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN17325124
Enrollment
120
Registered
2016-11-07
Start date
2016-11-15
Completion date
Unknown
Last updated
2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Critical care, Primary sub-specialty: Critical care

Interventions

All patients will be monitored during their stay in ICU up to five days from the first blood culture i.e. to the time of the final blood culture report. On the first day two blood samples will be take

Sponsors

University College London Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient has blood culture taken in critical care unit 2. Age >18 years 3. Not palliative treatment 4. Discharge expected within 48 hours 5. Death not imminent 6. Blood culture positive <12 hours 7. Test cannot be completed on the day sample taken

Exclusion criteria

Exclusion criteria: 1. Patient < 18 years of age 2. The treatment intent is palliative; the clinician is not committed to aggressive treatment 3. Treating clinician expects the patient to be discharged from the ICU on the day of evaluation (i.e. assessment for inclusion) or the following day 4. Death is deemed imminent and inevitable

Design outcomes

Primary

MeasureTime frame
Whether the clinician’s decision on continuing antibiotic would have been affected by the test result if it had been available is assessed through clinician interviews at 24 and 48 hours.

Secondary

MeasureTime frame
Number of defined daily doses of antibiotic that would have been saved if the clinician had decided to stop antibiotics upon receiving a negative test result is determined by reviewing the patient’s current antibiotic treatment and expected duration at 24 or 48 hours.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026